Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol in relapsing multiple sclerosis
NCT01198132Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Nov 2009
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in multiple sclerosis (MS), sponsored by Merck KGaA. Primary endpoint: Annualized Relapse Rate at 96 weeks. Started Nov 2009; status: completed.
02
Drugs
vitamin d
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01198132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198132.